elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Genetic enhancement
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Genetic enhancement
RIS
0.001
(Research Intensity Score)
Papers
185
Top papers
Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials
2024 · 169 citations
Gene therapy: Comprehensive overview and therapeutic applications
2022 · 365 citations
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
2021 · 453 citations
Pearl Millet: A Climate-Resilient Nutricereal for Mitigating Hidden Hunger and Provide Nutritional Security
2021 · 291 citations
Time-restricted feeding mitigates obesity through adipocyte thermogenesis
2022 · 164 citations
Newest papers
Engineering delivery platforms for CRISPR-Cas and their applications in healthcare, agriculture and beyond
2026 · 13 citations
Encapsulation of AAVs into Protein Vault Nanoparticles as a Novel Solution to Gene Therapy’s Neutralizing Antibody Problem
2026 · 2 citations
Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease
2026 · 2 citations
Pompe Disease: Pathogenesis, Molecular Mechanisms, Neurological Aspects, Diagnostics and Modern Therapeutic Approaches
2026 · 2 citations
Biogenic Selenium Nanoparticles Potentiate Anti-Mesothelin CAR-T Cell Therapy in a Syngeneic TNBC Model
2026 · 2 citations
A sample from the 100 top papers behind Genetic enhancement.
Create a free account to browse them all →
Genetic enhancement's history
Research intensity over time
Explore Genetic enhancement's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Genetic enhancement's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link